David Botstein
Director at Pacific Biosciences Of California, Inc. (PACB)
David Botstein has filed 4 insider reports with the SEC since February 2021, as director at Pacific Biosciences Of California, Inc. (PACB). David Botstein made no open-market purchases or sales in the last 12 months. The latest filing, on May 26, 2023, reports grant or award at Pacific Biosciences Of California, Inc. (PACB).
- Filings
- 4
- Companies
- 1
- Bought on market
- None
- Sold on market
- $7.94M
Companies where David Botstein is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 0 | $7.94M | $1.83 | May 26, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- May 24, 2023PACBSEC Form 4 filed by Botstein DavidForm 4Grant or award
- May 25, 2022PACBSEC Form 4 filed by Botstein DavidForm 4Grant or award
- Jun 16, 2021PACBSEC Form 4 filed by Botstein DavidForm 4Grant or award
- Feb 12, 2021-$7.94MPACBSEC Form 4: David Botstein exercised 160,000 units of Common Stock at a strike of $4.42 and sold $7,939,764 worth of Common Stock (160,000 units at $49.62)Form 4Exercise or conversion of a derivativeOpen-market sale
Compare David Botstein with
- David Botstein vs Kathy Ordonez1 shared
- David Botstein vs Mark Van Oene1 shared
- David Botstein vs Marshall Mohr1 shared
- David Botstein vs Christopher Gibson1 shared
- David Botstein vs Christopher M Smith1 shared
- David Botstein vs Hannah Valantine1 shared
Other insiders at the same companies
- Kathy OrdonezPACB
- William MeyerPACB
- Mark Van OenePACB
- Marshall MohrPACB
- Christopher GibsonPACB
- Christopher M SmithPACB
- Hannah ValantinePACB
- Randall S LivingstonPACB
- William W. EricsonPACB
- John F MilliganPACB
- James R Gibson IIPACB
- Christian O HenryPACB
- Michele FarmerPACB
- Lucy ShapiroPACB
Questions about David Botstein
- What is David Botstein's role at Pacific Biosciences Of California, Inc.?
- David Botstein reports to the SEC as director at Pacific Biosciences Of California, Inc. (PACB), according to the latest filing on May 26, 2023.
- Has David Botstein bought or sold stock recently?
- The most recent open-market sale was on February 12, 2021: sold 160,000 shares of Pacific Biosciences Of California, Inc. (PACB) for $7.94M at an average of $49.62.
- How do I get alerts when David Botstein files?
- Follow David Botstein on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by David Botstein (SEC CIK 0001554630). Totals count each trade once, skipping amendments whose original is on file, from Feb 18, 2021 on. View on SEC EDGAR